Second-generation antidepressant: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett (New page: {{subpages}} '''Second-generation antidepressants''' are a "structurally and mechanistically diverse group of drugs that are not tricyclics or [[monoamine oxid...) |
imported>Robert Badgett |
||
| Line 3: | Line 3: | ||
==Classification== | ==Classification== | ||
Second-generation antidepressant are classified by the [[biogenic amine receptor]] that they affect. | |||
===Selective serotonin reuptake inhibitors(SSRI)=== | |||
* [[Fluoxetine]] | |||
* [[Sertraline]] | |||
===Serotonin 5-HT2–receptor agonist=== | |||
* [[Nefazodone]] | |||
===Serotonin norepinephrine reuptake inhibitors (SNRI)=== | |||
* [[Duloxetine]] | |||
===Norepinephrine uptake inhibitor=== | |||
* [[Maprotiline]] | |||
===Dopamine reuptake inhibitor=== | |||
* [[Bupropion]] | |||
==References== | ==References== | ||
<references/> | <references/> | ||
Revision as of 13:31, 25 February 2008
Second-generation antidepressants are a "structurally and mechanistically diverse group of drugs that are not tricyclics or monoamine oxidase inhibitors. The most clinically important appear to act selectively on serotonergic systems, especially by inhibiting serotonin reuptake."[1]
Classification
Second-generation antidepressant are classified by the biogenic amine receptor that they affect.
Selective serotonin reuptake inhibitors(SSRI)
Serotonin 5-HT2–receptor agonist
Serotonin norepinephrine reuptake inhibitors (SNRI)
Norepinephrine uptake inhibitor
Dopamine reuptake inhibitor
References
- ↑ Anonymous (2024), Second-generation antidepressants (English). Medical Subject Headings. U.S. National Library of Medicine.